AptarGroup (ATR) Projected to Post Quarterly Earnings on Thursday

AptarGroup (NYSE:ATR) is projected to release its Q3 2026 results after the market closes on Thursday, October 29th. Analysts expect the company to announce earnings of $1.47 per share and revenue of $980.76 million for the quarter. AptarGroup has set its Q3 2026 guidance at 1.450-1.530 EPS. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Friday, October 30, 2026 at 9:00 AM ET.

AptarGroup (NYSE:ATR) last posted its quarterly earnings results on Thursday, July 30th. The industrial products company reported $1.42 EPS for the quarter, beating the consensus estimate of $1.35 by $0.07. AptarGroup had a return on equity of 13.31% and a net margin of 9.22%. The firm had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.01 billion. During the same quarter last year, the firm earned $1.66 earnings per share. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, analysts expect AptarGroup to post $5.47 EPS for the current fiscal year and $6.14 EPS for the next fiscal year.

AptarGroup Price Performance

NYSE:ATR opened at $125.67 on Thursday. AptarGroup has a one year low of $103.23 and a one year high of $146.91. The stock has a market cap of $7.99 billion, a PE ratio of 22.73, a P/E/G ratio of 3.90 and a beta of 0.34. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.10 and a current ratio of 1.61. The stock has a 50 day moving average price of $126.23 and a 200 day moving average price of $125.16.

Insider Activity

In related news, CEO Stephan B. Tanda sold 9,838 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $136.16, for a total value of $1,339,542.08. Following the completion of the transaction, the chief executive officer directly owned 238,729 shares in the company, valued at approximately $32,505,340.64. This represents a 3.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Gael Touya sold 3,740 shares of the stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $133.76, for a total value of $500,262.40. Following the completion of the transaction, the chief executive officer owned 29,102 shares of the company’s stock, valued at $3,892,683.52. The trade was a 11.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 23,197 shares of company stock worth $3,134,828 in the last 90 days. 0.73% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several analysts have issued reports on ATR shares. Bank of America upgraded AptarGroup from a “neutral” rating to a “buy” rating and set a $173.00 target price for the company in a report on Tuesday, July 14th. UBS Group started coverage on AptarGroup in a report on Friday, October 9th. They set a “neutral” rating and a $135.00 price target on the stock. Deutsche Bank Aktiengesellschaft started coverage on shares of AptarGroup in a research report on Wednesday, October 7th. They set a “buy” rating and a $150.00 price target on the stock. Wells Fargo & Company boosted their price target on shares of AptarGroup from $145.00 to $155.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Finally, Raymond James Financial reissued an “outperform” rating and issued a $160.00 price objective on shares of AptarGroup in a report on Wednesday, July 15th. Six research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, AptarGroup has an average rating of “Moderate Buy” and a consensus price target of $164.14.

About AptarGroup

AptarGroup, Inc (NYSE: ATR) develops and manufactures dispensing, sealing and delivery systems for the pharmaceutical, beauty, personal care, food and beverage markets. Its products are designed to control, protect and dispense a wide range of liquids, creams, lotions, fragrances and other formulations.

The company’s offerings include pumps, valves, closures, aerosol systems and other dispensing components, as well as drug-delivery technologies. Through its pharmaceutical business, Aptar supports nasal, pulmonary, ophthalmic, dermal and injectable applications, serving pharmaceutical and biotechnology companies with components and systems used in prescription, over-the-counter and consumer health products.

Aptar serves customers internationally through manufacturing, research and development and commercial operations across North America, Europe, Asia and other global markets.